REINHARDT MAX
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to REINHARDT MAX. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| OFIX | President, Global Spine | Sale | 1,643 | $11.64 | $19,125 | Jun 11, 2025 |
| OFIX | President, Global Spine | Award / Grant | 14,723 | — | — | Mar 3, 2025 |
| OFIX | President, Global Spine | Award / Grant | 14,401 | $13.02 | $187,501 | Jun 10, 2024 |
| PCRX | President, Rest of World | Sale | 1,054 | $38.99 | $41,095 | Jun 7, 2023 |
| PCRX | President, Rest of World | Sale | 1,380 | $58.00 | $80,040 | Oct 7, 2022 |
| PCRX | President, Rest of World | Sale | 2,433 | $62.00 | $150,846 | Jun 6, 2022 |
| PCRX | President, Rest of World | Option Exercise | 12,500 | $42.54 | $531,750 | Apr 21, 2022 |
| PCRX | President, Rest of World | Option Exercise | 12,500 | $42.54 | $531,750 | Apr 20, 2022 |
| PCRX | President, Rest of World | Sale | 421 | $59.76 | $25,159 | Jul 2, 2021 |
| PCRX | President, Rest of World | Award / Grant | 7,000 | — | — | Jun 9, 2021 |
| PCRX | President, Rest of World | Sale | 1,222 | $61.04 | $74,591 | Jun 7, 2021 |
| PCRX | President | Sale | 110 | $60.81 | $6,689 | Jan 6, 2021 |
| PCRX | President | Sale | 4,000 | $62.67 | $250,680 | Nov 13, 2020 |
| PCRX | President | Sale | 22,532 | $59.75 | $1,346,287 | Sep 17, 2020 |
| PCRX | President | Award / Grant | 14,000 | — | — | Jun 9, 2020 |